Legal & General Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $389K | Sell |
112,316
-16,899
| -13% | -$58.5K | ﹤0.01% | 2514 |
|
|
2025
Q1 | $339K | Buy |
129,215
+4,329
| +3% | +$11.3K | ﹤0.01% | 2517 |
|
|
2024
Q4 | $515K | Buy |
124,886
+1,589
| +1% | +$6.55K | ﹤0.01% | 2446 |
|
|
2024
Q3 | $873K | Buy |
123,297
+35,491
| +40% | +$251K | ﹤0.01% | 2283 |
|
|
2024
Q2 | $572K | Buy |
87,806
+719
| +0.8% | +$4.69K | ﹤0.01% | 2373 |
|
|
2024
Q1 | $723K | Buy |
87,087
+11,288
| +15% | +$93.7K | ﹤0.01% | 2299 |
|
|
2023
Q4 | $835K | Hold |
75,799
| – | – | ﹤0.01% | 2260 |
|
|
2023
Q3 | $637K | Sell |
75,799
-849
| -1% | -$7.14K | ﹤0.01% | 2338 |
|
|
2023
Q2 | $963K | Buy |
76,648
+1,588
| +2% | +$19.9K | ﹤0.01% | 2239 |
|
|
2023
Q1 | $1.24M | Buy |
75,060
+12,726
| +20% | +$210K | ﹤0.01% | 2081 |
|
|
2022
Q4 | $931K | Sell |
62,334
-883
| -1% | -$13.2K | ﹤0.01% | 2169 |
|
|
2022
Q3 | $1.41M | Buy |
63,217
+2,640
| +4% | +$59.1K | ﹤0.01% | 2023 |
|
|
2022
Q2 | $1.02M | Buy |
60,577
+9,527
| +19% | +$160K | ﹤0.01% | 2154 |
|
|
2022
Q1 | $1.53M | Buy |
51,050
+386
| +0.8% | +$11.6K | ﹤0.01% | 2092 |
|
|
2021
Q4 | $1.56M | Buy |
50,664
+11,121
| +28% | +$342K | ﹤0.01% | 2119 |
|
|
2021
Q3 | $1.25M | Buy |
39,543
+6,322
| +19% | +$199K | ﹤0.01% | 2180 |
|
|
2021
Q2 | $1.22M | Buy |
33,221
+7,393
| +29% | +$270K | ﹤0.01% | 2159 |
|
|
2021
Q1 | $893K | Buy |
25,828
+12,157
| +89% | +$420K | ﹤0.01% | 2215 |
|
|
2020
Q4 | $568K | Sell |
13,671
-23,461
| -63% | -$975K | ﹤0.01% | 2233 |
|
|
2020
Q3 | $1.58M | Buy |
+37,132
| New | +$1.58M | ﹤0.01% | 1865 |
|